DrugDevCovid19

Tracking the relevant researches of CADD drug development against COVID-19

Lypressin

ID MW HBD HBA
644076  1056.21312
RB NOA Rings logP
23254-3.86

Function

DrugBank ID:

DB14642


Description:

Not Available [DrugBank]

Targets:

Vasopressin V1a receptor (Humans); Vasopressin V2 receptor (Humans); Vasopressin V1b receptor (Humans) [DrugBank]

Pharmacodynamics:

Not Available [DrugBank]

Structures

SMILES:

NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O

2D structures:  

3D structures:  

Docking in target protein

Receptor: Mpro

Docking Site: Catalytic pocket

Ligand: Lypressin

Vina score: -7.5

Off-target analysis based on ligand similarity (Homo sapiens)

Step 1 - Target prediction for Lypressin: SwissTargetPrediction

Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of Lypressin in the SMILES input box.

Step 2 - Blind docking for Lypressin: CB-Dock

Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of Lypressin to perform blind docking.